Acorah Software Products - Accounts Production15.0.600falsetruefalsetrueNo description of principal activity5 July 202331 March 202431 March 202414983873Mrs Shezana Azamiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure149838732023-07-04149838732024-03-31149838732023-07-052024-03-3114983873frs-core:CurrentFinancialInstruments2024-03-3114983873frs-bus:PrivateLimitedCompanyLtd2023-07-052024-03-3114983873frs-bus:FilletedAccounts2023-07-052024-03-3114983873frs-bus:Micro-entities2023-07-052024-03-3114983873frs-bus:AuditExempt-NoAccountantsReport2023-07-052024-03-3114983873frs-bus:Director12023-07-052024-03-31
Registered number: 14983873
SHEZANAPHARMA LIMITED
Unaudited Financial Statements
For the Period 5 July 2023 to 31 March 2024
AMCI ASSOCIATES LTD
SHEZANAPHARMA LIMITED
Balance Sheet
As At 31 March 2024
Balance Sheet
Registered number: 14983873
31 March 2024
£
Fixed assets
1,114
Current assets
36,781
Creditors: Amounts Falling Due Within One Year
(28,094)
NET CURRENT ASSETS
8,687
TOTAL ASSETS LESS CURRENT LIABILITIES
9,801
NET ASSETS
9,801
CAPITAL AND RESERVES
9,801
Notes
1.General Information
SHEZANAPHARMA LIMITED is a private company, limited by shares, incorporated in England & Wales, registered number 14983873. The registered office is 18 Highwood Avenue, Solihull, B92 8QX.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.